OpenURL Connection Search

Select item for more details and to access through your institution.

DOSE FINDING STUDY TO ASSESS SAFETY, PK AND EFFICACY OF FIMEPINOSTAT (CUDC‐907) WITH VENETOCLAX OR RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 561, doi. 10.1002/hon.9_2632
By:
- Younes, A.;
- Batlevi, C.L.;
- Cohen, J.B.;
- Kelly, K.;
- Landsburg, D.J.;
- Patel, K.;
- Phillips, T.;
- Smith, S.;
- Westin, J.;
- Ma, A.W.;
- Grayson, D.;
- Barta, S.
Publication type:
Article
INCIDENCE AND TREATMENT OUTCOMES OF PATIENTS WITH TRANSFORMED MARGINAL ZONE LYMPHOMA TREATED WITH RCHOP‐LIKE REGIMENS.
Published in:
Hematological Oncology, 2019, v. 37, p. 264, doi. 10.1002/hon.74_2630
By:
- Rajeeve, S.;
- Bobillo, S.V.;
- Zelenetz, A.D.;
- Straus, D.J.;
- Palomba, M.L.;
- Noy, A.;
- Horwitz, S.M.;
- Moskowitz, A.J.;
- Hamlin, P.A.;
- Matasar, M.J.;
- Kumar, A.;
- Batlevi, C.L.;
- Keudell, G.;
- Yahalom, J.;
- Dogan, A.;
- Drill, E.;
- Younes, A.;
- Joffe, E.
Publication type:
Article
PHASE I CLINICAL TRIAL OF CD19‐TARGETED 19‐28Z/4‐1BBL "ARMORED" CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION.
Published in:
Hematological Oncology, 2019, v. 37, p. 166, doi. 10.1002/hon.124_2629
By:
- Batlevi, C.L.;
- Palomba, M.L.;
- Park, J.;
- Mead, E.;
- Santomasso, B.;
- Riviere, I.;
- Wang, X.;
- Senechal, B.;
- Furman, R.;
- Yang, J.;
- Kane, P.;
- Hall, M.;
- Bernal, Y.;
- Lund, N.;
- Diamonte, C.;
- Pineda, J.;
- Halton, E.;
- Moskowitz, C.;
- Younes, A.;
- Sadelain, M.
Publication type:
Article
IMPACT OF PET IMAGING AND HISTOLOGIC TRANSFORMATION ON THE PROGNOSIS OF EARLY DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 152, doi. 10.1002/hon.109_2629
By:
- Batlevi, C.L.;
- Sha, F.;
- Alperovich, A.;
- Ni, A.;
- Smith, K.;
- Ying, Z.;
- Hamlin, P.;
- Horwitz, S.M.;
- Kumar, A.;
- Matasar, M.;
- Moskowitz, A.J.;
- Moskowitz, C.H.;
- Noy, A.;
- Palomba, M.L.;
- Portlock, C.;
- Straus, D.;
- Boccomini, C.;
- Tucci, A.;
- Zelenetz, A.D.;
- Seshan, V.E.
Publication type:
Article
DOSE FINDING STUDY TO ASSESS SAFETY, PK AND EFFICACY OF FIMEPINOSTAT (CUDC‐907) WITH VENETOCLAX OR RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 561, doi. 10.1002/hon.9_2632
By:
- Younes, A.;
- Batlevi, C.L.;
- Cohen, J.B.;
- Kelly, K.;
- Landsburg, D.J.;
- Patel, K.;
- Phillips, T.;
- Smith, S.;
- Westin, J.;
- Ma, A.W.;
- Grayson, D.;
- Barta, S.
Publication type:
Article
INCIDENCE AND TREATMENT OUTCOMES OF PATIENTS WITH TRANSFORMED MARGINAL ZONE LYMPHOMA TREATED WITH RCHOP‐LIKE REGIMENS.
Published in:
Hematological Oncology, 2019, v. 37, p. 264, doi. 10.1002/hon.74_2630
By:
- Rajeeve, S.;
- Bobillo, S.V.;
- Zelenetz, A.D.;
- Straus, D.J.;
- Palomba, M.L.;
- Noy, A.;
- Horwitz, S.M.;
- Moskowitz, A.J.;
- Hamlin, P.A.;
- Matasar, M.J.;
- Kumar, A.;
- Batlevi, C.L.;
- Keudell, G.;
- Yahalom, J.;
- Dogan, A.;
- Drill, E.;
- Younes, A.;
- Joffe, E.
Publication type:
Article
PHASE I CLINICAL TRIAL OF CD19‐TARGETED 19‐28Z/4‐1BBL "ARMORED" CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION.
Published in:
Hematological Oncology, 2019, v. 37, p. 166, doi. 10.1002/hon.124_2629
By:
- Batlevi, C.L.;
- Palomba, M.L.;
- Park, J.;
- Mead, E.;
- Santomasso, B.;
- Riviere, I.;
- Wang, X.;
- Senechal, B.;
- Furman, R.;
- Yang, J.;
- Kane, P.;
- Hall, M.;
- Bernal, Y.;
- Lund, N.;
- Diamonte, C.;
- Pineda, J.;
- Halton, E.;
- Moskowitz, C.;
- Younes, A.;
- Sadelain, M.
Publication type:
Article
IMPACT OF PET IMAGING AND HISTOLOGIC TRANSFORMATION ON THE PROGNOSIS OF EARLY DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 152, doi. 10.1002/hon.109_2629
By:
- Batlevi, C.L.;
- Sha, F.;
- Alperovich, A.;
- Ni, A.;
- Smith, K.;
- Ying, Z.;
- Hamlin, P.;
- Horwitz, S.M.;
- Kumar, A.;
- Matasar, M.;
- Moskowitz, A.J.;
- Moskowitz, C.H.;
- Noy, A.;
- Palomba, M.L.;
- Portlock, C.;
- Straus, D.;
- Boccomini, C.;
- Tucci, A.;
- Zelenetz, A.D.;
- Seshan, V.E.
Publication type:
Article
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 171, doi. 10.1002/hon.2438_30
By:
- Kumar, A.;
- Casulo, C.;
- Advani, R.;
- Budde, E.;
- Barr, P.M.;
- Batlevi, C.L.;
- Chen, R.;
- Constine, L.S.;
- Courtien, A.I.;
- Dandapani, S.V.;
- Drullinsky, P.;
- Friedberg, J.W.;
- Hamlin, P.A.;
- Hoppe, R.T.;
- Matasar, M.J.;
- McArthur, G.N.;
- Miller, S.T.;
- Moskowitz, A.J.;
- Noy, A.;
- Schoder, H.
Publication type:
Article

Found: 9